W Ursae Majoris

Aviva Systems Biology Launches AvivaBlot ECL Reagents for Western Blot

Retrieved on: 
Monday, April 11, 2022

SAN DIEGO, April 11, 2022 /PRNewswire/ -- Aviva Systems Biology , a market leader in antibodies, immunoassay kits, and recombinant proteins for life science research, today announced the launch of its AvivaBlot product line of ECL reagents for western blot application.

Key Points: 
  • SAN DIEGO, April 11, 2022 /PRNewswire/ -- Aviva Systems Biology , a market leader in antibodies, immunoassay kits, and recombinant proteins for life science research, today announced the launch of its AvivaBlot product line of ECL reagents for western blot application.
  • To ensure researchers achieve the best from their western blots, the AvivaBlot ECL reagents are easy-to-use, high quality, and affordable for a variety of western blot detection needs.
  • "For nearly 20 years Aviva Systems Biology has supported customers with thousands of antibodies validated in Western Blot, the primary workhorse application for protein analysis in most research settings.
  • We are excited to now provide best-in-class ECL detection reagents that will support Aviva customers complete Western Blot workflow needs," said Kevin Harvey, Ph.D., President.